Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19
Amy J Patel1, Stanislaw P Klek1, Virginia Peragallo-Dittko2
1Division of Endocrinology, Diabetes, and Metabolism, New York University Long Island School of Medicine, Mineola, New York.
Insights
This study found no significant link between hemoglobin A1C (HbA1C) levels and poor outcomes in hospitalized patients with diabetes and COVID-19. Therefore, HbA1C should not be used for risk stratification in this patient group.
Area of Science:
- Internal Medicine
- Endocrinology
- Infectious Diseases
Background:
- Diabetes mellitus is a significant risk factor for severe COVID-19.
- Glycemic control, indicated by Hemoglobin A1C (HbA1C), is crucial in managing diabetic patients.
- The impact of HbA1C levels on COVID-19 outcomes in hospitalized diabetic patients requires further investigation.
Purpose of the Study:
- To investigate the correlation between Hemoglobin A1C (HbA1C) levels and clinical outcomes in hospitalized patients with diabetes and COVID-19.
- To determine if HbA1C can be used for risk stratification in this population.
Main Methods:
- Retrospective, single-center observational study.
- Inclusion of hospitalized patients with confirmed COVID-19 and diabetes (HbA1C ≥6.5% or history).
- Categorization of HbA1C levels into four quartiles for outcome analysis.
Main Results:
- No statistically significant differences in in-hospital mortality, ICU admission, mechanical ventilation, or length of stay were observed across HbA1C quartiles.
- Acute kidney injury was less frequent in the highest HbA1C quartile (>9%).
- A total of 506 patients were analyzed.
Conclusions:
- No significant association found between HbA1C levels and adverse clinical outcomes in hospitalized COVID-19 patients with diabetes.
- HbA1C levels are not recommended for risk stratification in this patient cohort.
- Further research may explore other glycemic markers or factors influencing outcomes.
Objective:
Diabetes is a known risk factor for severe coronavirus disease 2019 (COVID-19). We conducted this study to determine if there is a correlation between hemoglobin A1C (HbA1C) level and poor outcomes in hospitalized patients with diabetes and COVID-19.
Methods:
This is a retrospective, single-center, observational study of patients with diabetes (defined by an HbA1C level of ≥6.5% or known medical history of diabetes) who had a confirmed case of COVID-19 and required hospitalization. All patients were admitted to our institution between March 3, 2020, and May 5, 2020. HbA1C results for each patient were divided into quartiles: 5.1% to 6.7% (32-50 mmol/mol), 6.8% to 7.5% (51-58 mmol/mol), 7.6% to 8.9% (60-74 mmol/mol), and >9% (>75 mmol/mol). The primary outcome was in-hospital mortality. Secondary outcomes included admission to an intensive care unit, invasive mechanical ventilation, acute kidney injury, acute thrombosis, and length of hospital stay.
Results:
A total of 506 patients were included. The number of deaths within quartiles 1 through 4 were 30 (25%), 37 (27%), 34 (27%), and 24 (19%), respectively. There was no statistical difference in the primary or secondary outcomes among the quartiles, except that acute kidney injury was less frequent in quartile 4.
Conclusion:
There was no significant association between HbA1C level and adverse clinical outcomes in patients with diabetes who are hospitalized with COVID-19. HbA1C levels should not be used for risk stratification in these patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
Correlations
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Contingency Table


